-
Loading metrics
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study
- Takahiro Wakasaki,
- Tomomi Manako,
- Ryuji Yasumatsu,
- Hirotaka Hara,
- Satoshi Toh,
- Muneyuki Masuda,
- Moriyasu Yamauchi,
- Yuichiro Kuratomi,
- Emi Nishimura,
- Toranoshin Takeuchi
x
- Published: July 28, 2022
- https://doi.org/10.1371/journal.pone.0271907